Andrew Atz, MD
Chair, Department of Pediatrics
The overall goal of the program is to train academic specialists in Pediatric Hematology/Oncology (PHO). The proposed program will provide 3 years of clinical and research training. The trainee will acquire the skills and expertise required to be an independent Pediatric Hematologist/Oncologist with an academic career. Training objectives include the following: equip the trainee with the knowledge and skills to provide state of the art care to complex hematology/oncology patients acquire expertise in blood and marrow transplantation, and provide the experience necessary in clinical and basic research for a research career.
The first year is clinical and the last two years are primarily dedicated to research. The research activity is conducted either in the Division of Pediatric Hematology/Oncology or in any of the laboratories on campus involved in cancer research. Both clinical and research opportunities are available on the MUSC campus.
Goals are primarily aimed at gaining experience in the diagnosis of hematologic and oncologic disorders and daily management and comprehensive care of children with known hematologic or oncologic disorders. In general the expectations of a first year fellow involve demonstration of medical knowledge, comprehension of pathophysiology, development of differential diagnoses, formulation of management plans, dissemination of plans by presentations at tumor boards and other clinical conferences, and management of hematology and oncology patients in inpatient and outpatient settings. During the latter half of his/her first year, the fellow will identify a mentor(s) and a research project for the second and third years of fellowship. The fellow will also begin preparing a quality improvement project. The fellow will present as scheduled throughout the year in Journal Club, Morbidity and Mortality Conference, and Tumor Board.
In addition to the goals for the 1st year fellows, 2nd and 3rd years are expected to develop a research project, get appropriate IRB approval and animal research approval as necessary, apply for grant funding as necessary, carry out necessary experiments or clinical studies, and prepare the results for presentation and publication. Each trainee has a mentor in the laboratory to instruct him/her with the research projects. The mentors are established researchers in their field and the trainee can choose among all different programs available on campus. The Program Director advises the trainees throughout the selection of their mentors and projects. Special attention is placed in insuring the selected mentor has the time and is committed to the trainee’s development. Alternatively, if funding is available, instead of laboratory research, the trainee may enroll in the Master of Science in Clinical Research Program. The objective of the research training is to provide the trainee with the research capability to carry on as an independent investigator in the future. 2nd and 3rd year fellows are expected to develop increased independence in the formulation of management plans for patients. The only clinical duties during the second and third years are a one day/week continuity clinic and two months each year on in-patient service. The fellow will continue to develop and complete a quality improvement project. The fellow will continue to present as scheduled throughout the year in Journal Club, Morbidity and Mortality Conference, and Tumor Board. Additionally, the 2nd and 3rd year fellows will prepare and deliver lectures for the pediatric noon conference lecture series.
Learning modules are provided for biostatistics, teaching skills, and communication/psychosocial issues.
Fellows also receive group and one-on-one instruction in writing skills through the MUSC Center for Academic Excellence.
MUSC participates in the Pediatric Hematology\Oncology Fellowship Match. Applications are accepted through ERAS (Electronic Resident Application Service).